About OMass Therapeutics
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $310,000,000 · Series-B
Backed by Novo Holdings, GV
- Capital Raise
Raised $12,510,000 · Series-B
Backed by British Patient Capital
- Capital Raise
Raised $100,000,000 · Series-B
Backed by GV, Northpond Ventures
- Capital Raise
Series-A announced
Backed by Syncona Partners LLP, Oxford Science Enterprises
- Milestone
X account created (@omasstx)
596 followers
- Milestone
Company founded
Oxford, United Kingdom
- Milestone
Website domain registered
omass.com
Investors & Backers
Funding History
Round backers: Novo Holdings, GV, Janus Henderson Investors, Jefferson Life Sciences, Northpond Ventures, Oxford Science Enterprises, Sanofi Ventures, SV Health Investors, Syncona Partners LLP, University of Oxford
Round backers: British Patient Capital
Round backers: GV, Northpond Ventures, Sanofi Ventures, Oxford Science Enterprises, Syncona Partners LLP, University of Oxford
Round backers: Syncona Partners LLP, Oxford Science Enterprises, innovation.ox.ac.uk
Founders & Leadership
Hsin-Yung Yen
Founder
Idlir Liko
Founder
Jonathan Hopper
Founder
Jon Roffey
VP, Head of Medicinal Chemistry
Melissa Faris
Chief Business Officer
Ros Deegan
CEO
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com